Breast Cancer | Oncology Today with Dr Neil Love: PARP Inhibitors in Breast Cancer Edition

published 2 weeks ago by Dr Neil Love

Featuring a discussion on recent advances in the use of PARP inhibitors in breast cancer with Dr Susan Domchek, including the following topics: PARP Inhibitors in Breast Cancer — Susan M Domchek, MD (00:00) Case: A woman in her early 40s with ER-positive metastatic breast cancer and a BRCA2 mutation receives olaparib after experiencing disease progression on fulvestrant/palbociclib (20:31) Case: A woman in her early 30s with triple-negative breast cancer and a BRCA1 mutation is enrolled on the OlympiA trial (28:18) CME information and select publications

more episodes from Research To Practice | Oncology Videos